Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionCalifornia State Teachers Retirement System
Latest Disclosed Ownership105,132 shares
Latest Disclosed Value $ 3,123,472
California State Teachers Retirement System reports 32.29% increase in ownership of TVTX / Travere Therapeutics, Inc.

On May 15, 2026 - California State Teachers Retirement System filed a 13F-HR form disclosing ownership of 105,132 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $3,123,472 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 79,472 shares of Travere Therapeutics, Inc.. This represents a change in shares of 32.29% during the quarter. The current value of the position is $4,751,966 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 105,132 25,660 32.29 3,123 2.87 0.0033
2026-02-17 2025-12-31 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 79,472 -464 -0.58 3,037 58.95 0.0030
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 79,936 7,744 10.73 1,910 78.84 0.0020
2025-08-14 2025-06-30 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 72,192 0 0.00 1,068 -17.40 0.0012
2025-05-15 2025-03-31 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 72,192 0 0.00 1,294 2.86 0.0016
2025-03-18 2024-12-31 13F/A-1 TRAVERE THERAPEUTICS COMMON STOCK 89422G107 72,192 7,041 10.81 1,258 37.98 0.0015
2025-02-14 2024-12-31 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 72,192 7,041 1,258 0.0018
2025-04-04 2024-09-30 13F/A-1 TRAVERE THERAPEUTICS COMMON STOCK 89422G107 65,151 -2,215 -3.29 911 64.74 0.0011
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 65,151 -2,215 911 0.0013
2025-04-08 2024-06-30 13F/A-1 TRAVERE THERAPEUTICS COMMON STOCK 89422G107 67,366 -7,517 -10.04 554 -4.16 0.0007
2024-08-14 2024-06-30 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 67,366 -7,517 554 0.0008
2024-05-16 2024-03-31 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 74,883 -3,930 -4.99 577 -18.50 0.0007
2024-02-13 2023-12-31 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 78,813 3,389 4.49 709 5.04 0.0010
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 75,424 -4,564 -5.71 674 -45.11 0.0010
2023-08-21 2023-06-30 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 79,988 -187 -0.23 1,229 -31.89 0.0017
2023-05-09 2023-03-31 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 80,175 8,264 11.49 1,803 19.25 0.0027
2023-02-14 2022-12-31 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 71,911 1,407 2.00 1,512 -12.95 0.0024
2022-11-21 2022-09-30 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 70,504 -1,298 -1.81 1,737 -0.17 0.0029
2022-08-15 2022-06-30 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 71,802 -528 -0.73 1,740 -6.65 0.0028
2022-05-16 2022-03-31 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 72,330 -6,086 -7.76 1,864 -23.42 0.0025
2022-02-15 2021-12-31 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 78,416 2,386 3.14 2,434 32.00 0.0028
2021-11-15 2021-09-30 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 76,030 -4,395 -5.46 1,844 57.20 0.0024
2021-08-16 2021-06-30 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 80,425 -3,033 -3.63 1,173 -43.71 0.0015
2021-05-18 2021-03-31 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 83,458 9,419 12.72 2,084 3.27 0.0028
2021-02-16 2020-12-31 13F TRAVERE THERAPEUTICS COMMON STOCK 89422G107 74,039 0 0.00 2,018 47.62 0.0028
2020-11-17 2020-09-30 13F RETROPHIN COMMON STOCK 761299106 74,039 11,516 18.42 1,367 7.13 0.0022
2020-08-17 2020-06-30 13F RETROPHIN COMMON STOCK 761299106 62,523 -17 -0.03 1,276 39.91 0.0022
2020-05-13 2020-03-31 13F RETROPHIN COMMON STOCK 761299106 62,540 -705 -1.11 912 1.56 0.0020
2020-02-14 2019-12-31 13F RETROPHIN COMMON STOCK 761299106 63,245 -713 -1.11 898 21.19 0.0015
2019-11-15 2019-09-30 13F/A-1 RETROPHIN COMMON STOCK 761299106 63,958 206 0.32 741 -42.15 0.0014
2019-11-14 2019-09-30 13F RETROPHIN COMMON STOCK 761299106 63,752 0 1,281 2,524.2236
2019-08-14 2019-06-30 13F RETROPHIN COMMON STOCK 761299106 63,752 547 0.87 1,281 -10.42 0.0025
2019-05-09 2019-03-31 13F RETROPHIN COMMON STOCK 761299106 63,205 -1,405 -2.17 1,430 -2.19 0.0029
2019-02-13 2018-12-31 13F RETROPHIN COMMON STOCK 761299106 64,610 2,714 4.38 1,462 -17.77 0.0033
2018-11-14 2018-09-30 13F RETROPHIN COMMON STOCK 761299106 61,896 716 1.17 1,778 6.59 0.0035
2018-08-14 2018-06-30 13F RETROPHIN COMMON STOCK 761299106 61,180 1,224 2.04 1,668 24.38 0.0035
2018-05-15 2018-03-31 13F RETROPHIN COMMON STOCK 761299106 59,956 -313 -0.52 1,341 5.59 0.0029
2018-02-14 2017-12-31 13F RETROPHIN COMMON STOCK 761299106 60,269 -840 -1.37 1,270 -16.50 0.0026
2017-11-13 2017-09-30 13F RETROPHIN COMMON STOCK 761299106 61,109 -6,629 -9.79 1,521 15.84 0.0034
2017-08-15 2017-06-30 13F RETROPHIN COMMON STOCK 761299106 67,738 -3,600 -5.05 1,313 -0.30 0.0028
2017-05-12 2017-03-31 13F RETROPHIN COMMON STOCK 761299106 71,338 -3,300 -4.42 1,317 -6.79 0.0027
2017-02-14 2016-12-31 13F RETROPHIN COMMON STOCK 761299106 74,638 -2,100 -2.74 1,413 -17.71 0.0029
2016-11-09 2016-09-30 13F RETROPHIN COMMON STOCK 761299106 76,738 800 1.05 1,717 27.00 0.0035
2016-08-01 2016-06-30 13F RETROPHIN COMMON STOCK 761299106 75,938 1,869 2.52 1,352 33.60 0.0029
2016-05-16 2016-03-31 13F RETROPHIN COMMON STOCK 761299106 74,069 9,288 14.34 1,012 -19.04 0.0022
2016-01-29 2015-12-31 13F RETROPHIN COMMON STOCK 761299106 64,781 1,129 1.77 1,250 -3.10 0.0030
2015-10-30 2015-09-30 13F RETROPHIN COMMON STOCK 761299106 63,652 -200 -0.31 1,290 -39.06 0.0034
2015-08-03 2015-06-30 13F RETROPHIN COMMON STOCK 761299106 63,852 13,761 27.47 2,117 76.42 0.0051
2015-05-07 2015-03-31 13F RETROPHIN COMMON STOCK 761299106 50,091 10,800 27.49 1,200 149.48 0.0028
2015-02-11 2014-12-31 13F RETROPHIN COMMON STOCK 761299106 39,291 168 0.43 481 36.26 0.0011
2014-11-10 2014-09-30 13F RETROPHIN COMMON STOCK 761299106 39,123 323 0.83 353 -22.59 0.0009
2014-08-13 2014-06-30 13F RETROPHIN COMMON STOCK 761299106 38,800 4,200 12.14 456 -38.04 0.0011
2014-05-08 2014-03-31 13F/A-1 RETROPHIN COMMON STOCK 761299106 34,600 34,600 736 0.0019
2014-05-05 2014-03-31 13F RETROPHIN COMMON STOCK 761299106 34,600 736 0.0019
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.